Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer

References

• Agashe H, Sahoo K, Lagisetty P, Awasthi V. 2011. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids Surf B Biointerfaces 84:329–337.
   PubMed Web of Science ®Google Scholar
• Al-Omar A, Abdou S, De Robertis L, Marsura A, Finance C. 1999. Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line. Bioorg Med Chem Lett 9:1115–1120.
   PubMed Web of Science ®Google Scholar
• Arima H, Hagiwara Y, Hirayama F, Uekama K. 2006. Enhancement of antitumor effect of doxorubicin by its complexation with γ-cyclodextrin in pegylated liposomes. J Drug Target 14:225–232.
   PubMed Web of Science ®Google Scholar
• Baglole KN, Boland PG, Wagner BD. 2005. Fluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrins. J. Photochem. Photobiol. A 173:230−237.
   Web of Science ®Google Scholar
• Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. 2007. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnology 5:3.
   PubMedGoogle Scholar
• Bouquet W, Ceelen W, Fritzinger B, Pattyn P, Peeters M, Remon JP, Vervaet C. 2007. Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion: formulation and stability. Eur. J. Pharm. Biopharm. 66:391−397.
   PubMed Web of Science ®Google Scholar
• Castelli F, Puglisi G, Giammona G, Ventura CA. 1992. Effect of the complexation of some nonsteroidal antiinflammatory drugs with β-cyclodextrin on the interaction with phosphatidylcholine liposomes. Int. J. Pharmaceut. 88:1−8.
   Web of Science ®Google Scholar
• Fatouros DG, Hatzidimitriou K, Antimisiaris SG. 2001. Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release. Eur. J. Pharm. Sci. 13:287−296.
   PubMed Web of Science ®Google Scholar
• Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ. 2002. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105–111.
   PubMed Web of Science ®Google Scholar
• Kaur N, Puri R, Jain SK. 2010. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. AAPS PharmSciTech 11:528–537.
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, Kurzrock R. 2005. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322–1331.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. 2010. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol 62:1607–1621.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Gonzalez-Rodriguez ML, Rabasco AM, Mura P. 2005. Preparation and characterisation of liposomes encapsulating ketoprofen–cyclodextrin complexes for transdermal drug delivery. Int. J. Pharmaceut. 298:55−67.
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. 2007. Curcumin- phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharmaceut. 330:155−163.
   PubMed Web of Science ®Google Scholar
• Maruyama K. 2011. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63:161–169.
   PubMed Web of Science ®Google Scholar
• McCormack B, Gregoriadis G. 1994. Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int. J. Pharmaceut. 112:249−258.
   Web of Science ®Google Scholar
• Moghimi SM, Szebeni J. 2003. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–478.
   PubMed Web of Science ®Google Scholar
• Safavy A, Raisch KP, Mantena S, Sanford LL, Sham SW, Krishna NR, Bonner JA. 2007. Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem 50:6284–6288.
   PubMed Web of Science ®Google Scholar
• Sakai H, Masada Y, Horinouchi H, Ikeda E, Sou K, Takeoka S, Suematsu M, Takaori M, Kobayashi K, Tsuchida E. 2004. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J Pharmacol Exp Ther 311:874–884.
   PubMed Web of Science ®Google Scholar
• Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833.
   PubMed Web of Science ®Google Scholar
• Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–230.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Gescher AJ, Steward WP. 2005. Curcumin: the story so far. Eur J Cancer 41:1955–1968.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. 2009. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 57:9141–9146.
   PubMed Web of Science ®Google Scholar
• Tang B, Ma L, Wang HY, Zhang GY. 2002. Study on the supramolecular interaction of curcumin and β-cyclodextrin by spectrophotometry and its analytical application. J Agric Food Chem 50:1355–1361.
   PubMed Web of Science ®Google Scholar
• Tønnesen HH, Másson M, Loftsson T. 2002. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 244:127–135.
   PubMed Web of Science ®Google Scholar
• Wang Z, Leung MH, Kee TW, English DS. 2010. The role of charge in the surfactant-assisted stabilization of the natural product curcumin. Langmuir 26:5520–5526.
   PubMed Web of Science ®Google Scholar
• Yadav VR, Suresh S, Devi K, Yadav S. 2009. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 10:752–762.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. 2010. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 79:113–125.
   PubMed Web of Science ®Google Scholar
• Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK, Kim DD. 2007. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release 120:169–177.
   PubMed Web of Science ®Google Scholar
• Zhou H, Beevers CS, Huang S. 2011. The targets of curcumin. Curr Drug Targets 12:332–347.
   PubMed Web of Science ®Google Scholar